June 2026 IPO Wave: 7 Deals Worth $4.7B Hit Calendar
Seven IPOs led by INNIO’s $1.9B and Quantinuum’s $1B target a combined $4.7B as the Renaissance IPO Index outpaces the S&P 500 by 11.5 points YTD.
capital markets
Fed Revives ‘Payment Account’ Plan; Tier 3 Reviews Paused
The Fed re-proposed a limited ‘payment account’ for non-bank fintechs and novel-charter institutions, freezing Tier 3 master-account reviews.
China’s $885M Hong Kong Green Bond Debut Draws 10x Demand
China sold 6B yuan of sovereign green bonds in Hong Kong on May 28 — a 10x covered debut at 1.42% (3Y) and 1.56% (5Y).
Apollo, Blackstone Pitch $36B Debt to Power Anthropic TPUs
Apollo and Blackstone are arranging a record $36B debt deal to fund Anthropic’s Google TPU buildout — a watershed for AI-infra private credit.
EU Opens FSR Probe Into JD.com’s $2.5B Ceconomy Bid
Brussels launched an in-depth Foreign Subsidies Regulation probe into JD.com’s EUR2.2B/$2.5B takeover of MediaMarkt-Saturn parent Ceconomy AG.
FedEx Freight (FDXF) Joins S&P 500 as Spinoff Closes June 1
FedEx Freight Holding (FDXF) begins trading June 2, replaces EPAM in the S&P 500, and takes American Airlines’ Dow Transports slot as the $3.7B-funded spinoff closes.
OpenAI Files Confidential S-1; ~$1T IPO Eyed for Q4
OpenAI confidentially filed its S-1 around May 22, with Goldman Sachs and Morgan Stanley leading a Q4 IPO targeting up to a $1 trillion cap.
Quantinuum Sets QNT IPO at $45-$50; Targets $12.7B Cap
Quantinuum’s amended S-1 sets QNT IPO at $45-$50 per share on ~21M shares, implying a $12.7B valuation and up to $1.05B in proceeds. Here’s how it stacks up.
Kardigan Files for IPO (KARD): MyoKardia Veterans Return
Clinical-stage heart-drug developer Kardigan filed its S-1 for a Nasdaq IPO (ticker: KARD), backed by a JPM/Jefferies/Leerink/TD Cowen syndicate.
Russell 2026 Reconstitution: A $217B Day, Now Semi-Annual
FTSE Russell’s preliminary 2026 additions and deletions hit on May 22. The flip goes effective after the June 26 close – and now happens twice a year.